Investorideas.com - Cannabis Stock News: Village Farms International (TSX: $VFF.TO) (NASDAQ: $VFF) Completes $11.5 Million Public Offering of Common Shares, Including Exercise of Over-Allotment Option
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Tuesday 24 March 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 388 - Cannabis Deemed Essential (CSE: $SHRM.C)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 388 - Cannabis
Deemed Essential (CSE: $SHRM.C)
Delta, Kelowna, BC, March 24, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we are looking at how the COVID-19 Pandemic has pushed cannabis
fully away from fringe to “essential” and how psilocybin could be next.
A
recent
Forbes article discussed how, “In state after state, governors and public health officials are
deeming cannabis businesses “essential” operations that can stay open amid
coronavirus-related forced closures and stay-at-home mandates. People might not
be able to go bowling or see a movie in theaters, but they can still stock up
on marijuana.”
The article continues to discuss which states have declared
cannabis essential, such as California, and how even some states where cannabis
business was still being scrutinized heavily have even allowed the continuation
of medical and recreational cannabis operations.
In Canada, in recent news,
“Ontario
Premier Doug Ford announced Monday that all non-essential businesses in the
province will be required to shut down effective Tuesday at 11:59 p.m. for a
period of at least 14 days. A list of businesses that will remain open will be
released Tuesday, the government said in a release.”
The
article continued saying that, “Licensed cannabis stores will remain open in
Ontario during a provincial emergency shutdown of non-essential businesses
designed to limit the spread of COVID-19, according to two sources directly
familiar with the matter.”
Now
as cannabis pushes from recreational pass-time or fringe medication to
“essential” medication in North America, this is driving the push for another
fringe drug with massive potential, psilocybin.
There
has been a meme floating around the internet as of late during the COVID-19
Pandemic (image below), and while this may seem silly to some, many are taking
this opportunity to push local governments into reconsidering magic mushrooms.
In other recent news
from California, “a campaign to legalize psilocybin mushrooms in California is
asking the state to allow online signature gathering for their ballot petition,
arguing that the coronavirus outbreak necessitates an alternative means to put
the psychedelic reform measure before voters in November.”
Decriminalize
California, the group behind the proposed initiative, partnered with two other
campaigns in the state to write a letter to the governor, secretary of state
and attorney general, requesting the emergency policy change. It’s the latest
in a series of similar requests from drug policy reform campaigns across the
U.S., with activists scrambling to qualify their measures for state ballots
amid the pandemic.
In
news from Hawaii, “Two
members of the Hawaii Legislature introduced a set of resolutions aimed at
studying the medicinal applications of psilocybin in order to develop a plan
that ensures the availability of the compound for adult patients in the state.”
This leads to
companies like Champignon Brands Inc. (CSE:
SHRM), a health and wellness company specializing in the
formulation of a suite of medicinal mushrooms and mushroom-infused products,
who recently
introduced new proprietary intellectual property into
its vertically integrated alternative medicine product range. The Company
announced its entry into a definitive agreement, signed March 18, 2020, to
acquire Novo Formulations Ltd.
Novoformulations’
novel delivery system platforms, as well as complementary R&D advancements,
will accelerate the architecture of Champignon’s patent portfolio as the
Company persists in being a first mover in the existing consumer package goods
and emerging psychedelic medicine arenas.
Novoformulations is
a specialty biotechnology company focused on developing novel and innovative
delivery systems for the pharmaceutical and nutraceutical industries. The
Novoformulations team consists of a roster of PhDs and technician level scientists,
each with decades of experience building novel defensible medical IP, as well
as subsequently developing and commercially marketing proprietary delivery
platforms.
Novoformulations is
presently working with ketamine, anaesthetics and adaptogenics, as well as a
host of pharmaceuticals and natural molecules at a purpose-built GMP and
pharmaceutical (DIN) licensed facility located in Quebec, Canada, and an
accredited pharmacy in Ontario. There, the Company is actively formulating,
developing and commercializing bioavailable delivery platforms, including:
●
Transdermal (topical);
●
Intranasal;
●
Sublingual; and,
●
Novel oral and suppository.
Also based in
Quebec, Novoformulations’ manufacturing partner will process its novel delivery
platforms and formulations into marketable end products at its
40,000-square-foot GMP-certified, Health Canada and Federal Drug Administration
(FDA)-approved manufacturing facility.
Champignon plans to
leverage Novoformulations’ existing product development infrastructure and
licensed affiliates to pursue psilocybin and MDMA based formulations, with the
objective of developing and commercializing rapid onset treatments capable of
improving health outcomes, including Depression, PTSD and substance and alcohol
use disorders (DPS). The current marketplace for pharmacologic DPS treatments
in North America exceeds $10 billion annually.1
“The recent
acquisitions of Novoformulations and Artisan Growers are absolutely accretive
to each other and to our stated business objectives of enhancing the health and
wellbeing of millions of consumers via our suite of medicinal mushroom
extracts, mushroom-infused products and now novel delivery systems,” Champignon
Chief Executive Officer Gareth Birdsall commented.
“The existing infrastructure inherited from
these recent acquisitions positions us as a leading participant throughout the
entire alternative medicine lifecycle, from R&D to formulation,
manufacturing and end distribution. The end result will be a turnkey solution
that incorporates both standardized ingredient mixtures and pharmaceutical
grade products that can now be marketed via a variety of proprietary delivery
systems,” continued Gareth Birdsall. “The addition of Novoformulations allows
Champignon to deliver medications in a safer, more effective and more
expeditious manner than our peers, from bench top in the laboratory, to
preclinical and clinical trials. We are intent on the commercialization of
products throughout North America, as rapidly as is safely and effectively
practicable."
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration
Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
Monday 23 March 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 387 (CSE: $PLTH.C) (OTCQX: $PLNHF) (TSX: $VFF.TO) (NASDAQ: $VFF) (CSE: $IMCC.C)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 387 (CSE: $PLTH.C)
(OTCQX: $PLNHF) (TSX: $VFF.TO) (NASDAQ: $VFF) (CSE: $IMCC.C)
Delta, Kelowna, BC, March 23, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/03231PLTH-PLNHF-VFF-IMCC.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com "Potcast"
featuring cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In
today’s podcast we look at a few company announcements.
But
first, in recent
news, The
Alberta Cannabis Council (ACC), a not-for-profit industry trade group serving
the province’s cannabis industry stakeholders, shared a letter with the
Canadian government calling for it to grant the same access to economic relief
programs to the country’s cannabis industry.
The letter was
signed by 74 industry members and calls for the “equal and fair access to
significant support for all cannabis companies working to keep employees
employed, including access to wage subsidies as announced on March 18, 2020 by
the Prime Minister and Finance Minister.”
Additionally, the
letter asks that federal agencies offer “equal and fair access to funding
through federal agencies, EDC [Export Development Canada] or BDC [Business
Development Bank of Canada] as other industries have for credit instruments.
Presently, for example, BDC has indicated that the regulated cannabis sector
can not access the $10B in stimulus funding, part of which is available through
that crown corporation.”
John Carle, the
executive director for the ACC, along with the letter’s signatories, writes “We
are not asking for special treatment, but rather equitable treatment.”
The letter also
highlights the recent, non-COVID-19 related challenges the industry has faced
in recent months, including difficult access to investor capital and the loss
of more than 2,000 jobs across the industry.
“We are asking that
this industry, which has added a cumulative total of $8B to the Canadian GDP
over the course of the last year, specifically and explicitly be included in
all economic stimulus measures and provided the support that is being offered
to every other Canadian business at this time,” the letter reads.
Planet 13 Holdings
Inc. (CSE:
PLTH) (OTCQX:
PLNHF) announced last
Friday, March 20, 2020, that Nevada Gov. Steve Sisolak issued a declaration
ordering all recreational and medical marijuana dispensaries to close their
storefronts. Legal cannabis statewide will be available by delivery only. In
response to overwhelming customer demand, Planet 13 has significantly expanded
its delivery capabilities, moving from five to eight delivery vehicles, all of
which are now running twenty-four hours a day, seven days a week. The Company
expects to add an additional seven vehicles to its delivery fleet over the next
several days. Planet 13 offers delivery to Las Vegas and all other
municipalities in the greater Las Vegas Valley.
"We
have one of the largest delivery platforms in Nevada and will be expanding it
to ensure continuity of service to the greater Las Vegas Valley residents. As
one of the few companies with an existing delivery program, we have a
responsibility to our community to pick up the slack as other dispensaries
close," said Larry Scheffler and Bob Groesbeck, Co-CEOs and Co-Founders of
Planet 13.
Village Farms International,
Inc.
(TSX:
VFF)
(NASDAQ:
VFF)
announced that
its majority-owned joint venture for large-scale, low-cost, high-quality
cannabis production, Pure Sunfarms,
has received approval from Health Canada to operate the final components of its
65,000 square foot, state-of-the-art processing center located within the 1.1
million square foot Delta 3 greenhouse facility. The significantly expanded processing area
will enable Pure Sunfarms to generate additional production cost efficiencies,
further elevate the quality of its products, expand its product offerings and
increase its processing throughput.
Health
Canada's approval of the additional processing area permits Pure Sunfarms to
begin operation of:
●
11 additional drying rooms utilizing
advanced drying technology and processes to further enhance the quality of Pure
Sunfarms product;
●
5 additional packaging rooms;
●
2 additional testing areas;
●
6 additional storage areas; and,
●
7 extraction rooms with equipment capable
of processing 35,000 kilograms of biomass annually.
The
expanded processing center has been designed to satisfy full European Union GMP
compliance and certification requirements, which Pure Sunfarms is currently
pursuing. The 65,000 square foot
processing centre has capacity to serve both the Delta 3 and Delta 2 greenhouse
facilities, with a combined production area of 2.2 million square feet, at full
production.
"The
approval of this additional processing space enables Pure Sunfarms to enhance
our operations and quality processes to further support our commitment to
providing our customers with high-quality products at a great price," said
Mandesh Dosanjh, President and CEO, Pure Sunfarms. "Pure Sunfarms expects
to begin to realize the benefits of this new space in the coming quarter, allowing
us to build on our strong performance in the Canadian markets we serve."
"Pure
Sunfarms' success is directly attributable to the decades of large-scale
growing and operational experience contributed by Village Farms, low-cost
production, efficient capital investment, disciplined cost management and the
installation of a smart, highly talented and experienced leadership team,"
said Michael DeGiglio, CEO, Village Farms. "It is a business model that
positions Pure Sunfarms to continue to be a leader in the Canadian cannabis
sector for years to come. The expansion
of this processing area significantly strengthens Pure Sunfarms' capabilities
to produce high-quality products, supports its ongoing pursuit of even greater
production efficiencies and sets the stage for the introduction of new product
formats to build on its leading sales performance in dried cannabis
products."
IM Cannabis Corp. (CSE:
IMCC), one of the world's pioneering medical cannabis
companies with operations in Israel and across Europe,
announced that Focus Medical Herbs Ltd., a licensed medical
cannabis producer in Israel, has signed a 12-month definitive supply agreement
with Intelicanna Ltd. (TASE:INTL) for a
minimum of 500kg and up to 1,000kg of medical cannabis. Additional purchases
may be made by Focus Medical under this agreement without a change to the
contracted price paid to Intelicanna. The final products will be sold to pharmacies
in Israel under the IMC brand.
Focus
Medical is one of eight original licensed producers in Israel with over 10
years of experience growing high quality medical cannabis in the Israeli
market. Focus Medical has an exclusive commercial agreement with IMC to
distribute its production under the IMC brand. IMC's strategy in Israel is to
pursue additional supply agreements of this nature in order to continue
increasing market share of the IMC brand.
"The
demand for medical cannabis in Israel is rising quickly and securing additional
supply with a premium cultivator is an excellent long-term development for the
IMC brand. This agreement also represents strong third-party validation of
Focus Medical's intellectual property in plant genetics which are unique and
favored by many Israeli consumers," says Oren Shuster, Chief Executive
Officer of IMC. "IMC will continue to pursue similar arrangements with
other medical cannabis suppliers as pharmacies in Israel demand more and more
quality products for their patients over the long-term."
The
Supply Agreement between Focus Medical and Intelicanna is for a term of 12
months from the date of the first planting in Intelicanna's facility. The
Supply Agreement is contingent on Intelicanna receiving IMC-GAP approval by
June 15, 2020.
Intelicanna
will obtain access to Focus Medical's unique and proprietary genetics for the
purpose of delivering product under the Supply Agreement but the genetics will
remain the exclusive property of Focus Medical. Intelicanna may not sell,
transfer or perform research with the genetics it accesses through this Supply
Agreement without consent from Focus Medical. Under the Supply Agreement,
Intelicanna is responsible for all production activities but Focus Medical will
have access to Intelicanna's growing facility to monitor the entire growing
process.
Focus
Medical will make a deposit against future deliveries of 427,500 NIS
(approximately CDN$170,000) within a month from the execution date of the
Supply Agreement. The balance of payments for future deliveries will be made by
Focus Medical within 30 days from delivery by Intelicanna.
Panaxia (TelAviv: PNAX), the largest manufacturer and
distributor of pharmaceutical cannabis products in Israel, and its partner
Ultra Health have
announced the arrival in Israel of the first shipment of hemp
extract, having been awarded a first-of-its-kind permit to export cannabis oil
from the US to Israel.
This
unique license was granted to the companies in light of their recent
qualification to manufacture and distribute at their joint New Mexico (Bernalillo)
facility, including hemp extracts of particularly low (<0.3%) THC
concentrations. The companies have recently been licensed to manufacture
products at the New Mexico facility and distribute them throughout the US. The
facility was designed by Panaxia US and is operated by it while Ultra Health
supplies raw materials and distributes the products. Manufacturing had begun
this month, and the extracts delivered to Israel will be used in the
manufacture of CBD-rich medicinal cannabis products under the premium brand of
Axiban.
Panaxia
aims to produce within a short period of time an inventory large enough to
satisfy several months of demand of all Israeli patients requiring this care.
The products are designated for the Israeli market only and may not be
distributed outside of Israel. Panaxia's CBD-rich oil is targeted at specific
group of patients that require a miniscule dose of THC (categories C20, C24)
among whom is a large group of children suffering from epilepsy or autism
spectrum disorder (ASD).
Dr.
Dadi Segal, Panaxia CEO: "We are pleased to be able to extend care to our
patients in Israeli who are in acute need of this kind of medicinal cannabis
care. Panaxia's superb R&D capabilities combined with the added value of a
high-quality strategic company such as Ultra Health prove themselves time and
again, especially with regard to the high quality of the products and stringent
regulatory compliance."
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast and column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
Friday 20 March 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 386 (OTC: $EDXC) (CSE: $GGB.C) (OTCQB: $GGBXF) (CSE: $VIBE.C) (TSXV: $KHRN.V) (OTCQB: $KHRNF)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 386 (OTC: $EDXC) (CSE: $GGB.C) (OTCQB: $GGBXF) (CSE: $VIBE.C) (TSXV: $KHRN.V) (OTCQB: $KHRNF)
Delta, Kelowna, BC, March 20th, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/03201EDXC-GGB-GGBXF-VIBE-KHRN-KHRNF.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few company announcements.
CBD Unlimited, Inc.
(OTC: EDXC), formerly known as Endexx
Corporation, a provider of innovative phytonutrient-based food and nutritional
products, announced that Daniel S. Brandwein, D.P.M.,
F.A.C.F.A.S., Florida board-certified foot and ankle surgeon, joined the Board
of Directors.
“I
am honored to serve as a board member for CBD Unlimited and will continue to
promote the advancement of CBD use as part of patients’ overall health and
wellness protocol,” commented Dr. Brandwein. “During an original clinical study
in 2015, which was supported by CBD Unlimited, I observed and administered a
CBD trial for one month through my practice. After the month-long trial, my
patients were reporting relief from pain and tension. From there, I knew that I
needed to be part of something special and cutting-edge in order to provide the
very best care to my patients and to patients around the world.”
Daniel
S. Brandwein, D.P.M., F.A.C.F.A.S. is a board-certified surgeon specializing in
the field of podiatry. In addition to Dr. Brandwein’s expertise in pain
management and therapeutic treatments, Dr. Brandwein has participated in
clinical trials and has authored several scientific papers.
"Dr.
Brandwein witnessed exceptional outcomes in early-stage clinical studies
sponsored by CBD Unlimited and now his patients, as well as countless other patients,
rely on CBD Unlimited’s products as part of their day-to-day health regimen,”
commented Mr. Todd Davis, Chairman and Chief Executive Officer of CBD
Unlimited. “We are thrilled to welcome such a distinguished and accomplished
individual to our Advisory Board. Dr. Brandwein’s clinical expertise will prove
to be a significant advantage in the long-term objectives of the company,”
continued Davis.
CBD
Unlimited, Inc. develops and distributes all-natural CBD products derived from
cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products
range from oils, capsules, topicals, and pet products, all with the shared
purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD
soft chews for animal use that are formulated to promote health and support the
reduction of separation anxiety, pain, and inflammation. The science behind
these products involves over half a decade of research and experiments in order
to protect the accuracy in dosage and delivery of absorption per each serving.
Green Growth Brands
Inc.
(CSE: GGB) (OTCQB: GGBXF) announced that Peter Horvath is stepping down
as Chief Executive Officer and as a member of the Board of Directors effective
today. Mr. Horvath has served as CEO of
the Company since January 2019 and as a member of the Company's Board of
Directors since July 2018. Randy
Whitaker, the Company's current Chief Operating Officer will take over as
interim Chief Executive Officer, effective immediately. Mr. Whitaker has served as the Company's
Chief Operating Officer since February 2019.
The vacancy on the Company's Board of Directors will be filled in due
course.
Ms.
Carli Posner, the Chair of the Board of Directors, said "On behalf of the
Board and everyone at GGB, I would like to offer my heartfelt thanks to Peter
for his significant contribution and dedication to the Company and wish Peter
the best for his future endeavours."
Mr.
Horvath responded, "I am humbled to have worked with such amazing
professionals along this journey. Among
those individuals is Randy Whitaker, whom I am pleased has been named as
interim CEO. The Company will be in good hands with such a seasoned operator at
the helm, and I have full confidence in Randy to lead the Company during this
difficult time."
In
response to the ongoing COVID-19 pandemic and in accordance with the
recommendations of health professionals and other mall-based retailers, the
Company has elected to temporarily close all of its mall-based cannabidiol
("CBD") kiosk shops in an
effort order to protect its employees and customers from unnecessary exposure
to the COVID-19 virus. In connection
with this action, the Company will also suspend sales under its CBD e-commerce
platform.
The
Company's cannabis dispensaries, located in the Las Vegas, Nevada area, will
remain open for business subject to additional pandemic-related directives from
local authorities. The Company will continue to employ best practices and
adhere to such directives related to its operations in light of the COVID-19
pandemic.
The
Company will continue to pursue the previously announced sale of the CBD
business to The BRN Group Inc. In connection therewith, the Company will
continue to solicit and evaluate any potential superior offers under the
go-shop rights afforded to the Company as part of that announced transaction.
Vibe
Bioscience Ltd. (CSE: VIBE) announced, effective immediately, that it is
offering contactless ‘Curb-side’ Pick-Up at all Vibe By California locations in
addition to touchless delivery options and additional in-store safety measures.
While preparations
and information continue to develop across California for COVID-19 , Vibe is
working to ensure our clients and staff remain healthy. Our priority is on the
safety and well-being of our employees and clients. We have always taken great
pride in our clean and well-run stores, and in addition to increased frequency
of cleaning for all our stores, Vibe has a dedicated team member working full
time cleaning all frequently touched surfaces. We are also:
●
Providing
complimentary delivery service in Sacramento for those 65 years of age
and older and those with a pre-existing medical condition;
●
Limiting the number of clients and staff
permitted inside our stores at any given time and encouraging clients to
maximize their distance between our staff and other clients to reduce
transmission dynamics and potential communicability;
●
Encouraging clients to complete their
purchases online using our website, ensuring online orders are accurate and
available for immediate pick-up; and
●
Obtained local and State approvals to
provide compliant touchless pickup options at all locations.
Vibe continues to
work closely with international and State public health authorities to monitor
the situation regarding the Coronavirus. We will continue to follow the
guidance of local and international health authorities to make informed
decisions and provide our clients and staff with information as we continue to
learn and improve our processes.
Everyone has a
vital role during the management of this outbreak. We are confident that together we will
overcome this challenge soon by taking the necessary protective measures and
working collectively as a unified community.
As this issue continues to evolve, we remain committed to supporting our
clients and valued team.
For more
information on our touchless delivery and curbside pick-up option, please visit
www.vibebycalifornia.com.
Khiron Life
Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) announced that the Company has received
certification of Good Elaboration Practices for Magistral Preparations with
Cannabis (GEP). As a result, the Company is now fully authorized to manufacture
high- and low-THC magistral preparations in Colombia. The Company anticipates
fulfilling its first prescriptions of full-spectrum, high CBD formulations
within days. The Company anticipates
that it will also be fully authorized to fulfill prescriptions and dispense
psychoactive (high-THC) medical cannabis within the coming weeks, once the
pharmacies are authorized by the Narcotics National Fund (FNE).
"Today
is a hugely important milestone for Khiron. With this GEP certification we
begin a new phase in commercializing our medical cannabis product pipeline and
towards meeting our market potential. We have been preparing for this day for
three years. We have the capacity, established patient network, and now full
authorization to manufacture high- and low-THC magistral preparations, and to
fulfill prescriptions for non-psychoactive medicinal cannabis within
days," comments Alvaro Torres, Khiron CEO and director. "From day one
our mission has always been to model our business on serving patient needs, and
now we are delivering on that focus, targeting the millions of patients in
Colombia who have the potential to benefit from medical cannabis."
Khiron
has an established patient network in Colombia through its ILANS medical
facilities that treat over 120,000 patients with neurological, psychiatric,
respiratory, urological and orthopedic diseases, among others. ILANS patients
are serviced by the Colombian health insurance system. The Company also recently
opened Zerenia, a 15,000 sq. ft facility in Bogota that increases the Company's
patient capacity by 75%, offering a comprehensive suite of health and medical
services in alignment with insurance company partners.
Under
Colombian regulations, GEP certification is a manufacturing and processing
certification that is a mandatory requirement for commercializing customized
medical cannabis prescriptions, known as Magistral Preparations.
Commercializing customized medical cannabis prescriptions in Colombia involves
a lengthy and rigorous regulatory process that has seen the Company receive
licenses to cultivate high-THC and low-THC cannabis for domestic and export
sales, quotas to cultivate 9.3 tons of THC cannabis, and to extract THC
cannabis in Colombia. To-date, Khiron is the only company in Colombia to meet
all of these strict regulatory requirements, and, with the GEP certification
received today, becomes the first Company authorized to sell medical cannabis
in Colombia.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
Subscribe to:
Posts (Atom)
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...